Pacer Advisors, Inc. Denali Therapeutics Inc. Transaction History

Pacer Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$14.96 - $23.22 $17,398 - $27,004	-1,163 Reduced 57.43%	862 $20,000
Q1 2024 May 10, 2024	BUY	$15.83 - $23.35 $32,055 - $47,283	2,025 New	2,025 $41,000
Q2 2021 Jul 21, 2021	SELL	$50.3 - $78.44 $60,561 - $94,441	-1,204 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$53.8 - $81.53 $24,317 - $36,851	-452 Reduced 27.29%	1,204 $69,000
Q4 2020 Jan 20, 2021	SELL	$36.89 - $93.56 $7,894 - $20,021	-214 Reduced 11.44%	1,656 $139,000
Q3 2020 Oct 19, 2020	BUY	$23.13 - $38.84 $43,253 - $72,630	1,870 New	1,870 $67,000

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.